Bertani, L.; D’Alessandro, C.; Fornili, M.; Coppini, F.; Zanzi, F.; Carmisciano, L.; Geri, F.; Svizzero, G.B.; Rosi, E.M.; De Bernardi, A.;
et al. Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease. J. Clin. Med. 2023, 12, 6118.
https://doi.org/10.3390/jcm12196118
AMA Style
Bertani L, D’Alessandro C, Fornili M, Coppini F, Zanzi F, Carmisciano L, Geri F, Svizzero GB, Rosi EM, De Bernardi A,
et al. Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease. Journal of Clinical Medicine. 2023; 12(19):6118.
https://doi.org/10.3390/jcm12196118
Chicago/Turabian Style
Bertani, Lorenzo, Claudia D’Alessandro, Marco Fornili, Francesca Coppini, Federico Zanzi, Luca Carmisciano, Francesca Geri, Giovanni Baiano Svizzero, Emma Maria Rosi, Alice De Bernardi,
and et al. 2023. "Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease" Journal of Clinical Medicine 12, no. 19: 6118.
https://doi.org/10.3390/jcm12196118
APA Style
Bertani, L., D’Alessandro, C., Fornili, M., Coppini, F., Zanzi, F., Carmisciano, L., Geri, F., Svizzero, G. B., Rosi, E. M., De Bernardi, A., Ceccarelli, L., Mumolo, M. G., Baglietto, L., Bellini, M., De Bortoli, N., & Costa, F.
(2023). Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease. Journal of Clinical Medicine, 12(19), 6118.
https://doi.org/10.3390/jcm12196118
